New patient survey reveals: For people with atrial fibrillation, revers
89% of surveyed patients with atrial fibrillation (AF) are aware of potentia...
2018-07-02
文传商讯
Results of Phase III RELEVANCE Study Comparing REVLIMID plus Rituximab
SUMMIT, N.J. -- (BUSINESS WIRE) --Celgene Corporation (NASDAQ:CELG) today an...
2018-06-05
文传商讯
Results of Phase III OPTIMISMM Study Presented at ASCO 2018 Showed the
The OPTIMISMM study is the first Phase 3 Study to report findings for a trip...
2018-06-05
文传商讯
Efficacy and safety of OFEV reinforced in new presentations at ATS 2018
New analysis of the INPULSIS and TOMORROW trials suggests treatment with OFE...
2018-05-24
文传商讯
Boehringer Ingelheim R&D Pushes to Transcend Disease Boundaries
Promising first-in-class and potential medical breakthrough pipeline project...
2018-04-28
文传商讯
Boehringer Ingelheim Starts New Campaign: ‘Why wait in IPF?’
Rare Disease Day draws attention to the importance of early diagnosis and tr...
2018-03-01
文传商讯
OTEZLA (Apremilast) Phase III Data Showed Significant Improvements in P
RELIEF™ trial demonstrated statistically significant reductions in ora...
2018-02-25
文传商讯
New Data Show Benefit of Tagrisso in Patients with EGFR-mutated Non-sma
Phase III FLAURA trial demonstrates 52% risk reduction of CNS disease progre...
2017-11-21
文传商讯
New England Journal of Medicine Publishes Results of Phase III FLAURA T
Tagrisso demonstrated superior progression-free survival (PFS) of 18.9 month...
2017-11-21
文传商讯
AstraZeneca to Present Transformative Data at ESMO Asia 2017 Congress f
Phase III FLAURA data, including new data in patients with CNS metastases, c...
2017-11-21
文传商讯
